Atherosclerosis in Survivors of Kawasaki Disease

Journal of Pediatrics

Volumn 155, Issue 4, 2009, Pages 572-577

  Gupta Malhotra, Monesha ^a,c,e,f   Gruber, Dorota ^a   Abraham, Seena S ^a   Roman, Mary J ^b   Zabriskie, John B ^c   Hudgins, Lisa C ^c,d   Flynn, Patrick A ^a   Levine, Daniel M ^c,d   Okorie, Uzoma ^a   Baday, Aline ^d   Schiller, Myles S ^a   Maturi, Janet ^c   Meehan, Diane ^c   Dyme, Joshua ^a   Parker, Thomas S ^c,d   Wittkowski, Knut M ^c   Gersony, Welton M ^a,f   Cooper, Rubin S ^a,f  

^a Komansky Center for Children's Health   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e MEMORIAL HERMANN HOSPITAL   (United States)

^f College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; CYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LIPOPROTEIN A;

ADULT; ANAMNESIS; ARTERIAL STIFFNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; ECHOGRAPHY; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; SURVIVOR; WAIST HIP RATIO;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LIPIDS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RISK FACTORS; YOUNG ADULT;

EID: 70349164457     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.04.054     Document Type: Article

References (40)

1. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114 (2004) 1708-1733
2. Newburger J.W., Takahashi M., Gerber M.A., Gewitz M.H., Tani L.Y., Burns J.C., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110 (2004) 2747-2771
3. Sasaguri Y., and Kato H. Regression of aneurysms in Kawasaki disease: a pathological study. J Pediatr 100 (1982) 225-231
4. Mitani Y. Coronary endothelial dysfunction after Kawasaki disease. J Am Coll Cardiol 35 (2000) 821-823
5. Mitani Y., Okuda Y., Shimpo H., Uchida F., Hamanaka K., Aoki K., et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation 96 (1997) 454-461
6. Dhillon R., Clarkson P., Donald A.E., Powe A.J., Nash M., Novelli V., et al. Endothelial dysfunction late after Kawasaki disease. Circulation 94 (1996) 2103-2106
7. Newburger J.W., Burns J.C., Beiser A.S., and Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation 84 (1991) 625-631
8. Liu A.M., Ghazizadeh M., Onouchi Z., and Asano G. Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease. Microvasc Res 58 (1999) 10-27
9. Suzuki A., Miyagawa-Tomita S., Komatsu K., Nakazawa M., Fukaya T., Baba K., et al. Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease. Pediatr Int 46 (2004) 590-596
10. Roman M.J., Naqvi T.Z., Gardin J.M., Gerhard-Herman M., Jaff M., and Mohler E. American Society of Echocardiography report. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society for Vascular Medicine and Biology. Vasc Med 11 (2006) 201-211
11. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., and Fowkes F.G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112 (2005) 976-983
12. Kawasaki T. Clinical signs and symptoms of mucocutaneous lymph node syndrome (Kawasaki disease). Jpn J Med Sci Biol 32 (1979) 237-238
13. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 98 (1996) 649-658
14. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
15. Longnecker M.P., Lissner L., Holden J.M., Flack V.F., Taylor P.R., Stampfer M.J., et al. The reproducibility and validity of a self-administered semiquantitative food frequency questionnaire in subjects from South Dakota and Wyoming. Epidemiology 4 (1993) 356-365
16. Roman M.J., Pini R., Pickering T.G., and Devereux R.B. Non-invasive measurements of arterial compliance in hypertensive compared with normotensive adults. J Hypertens Suppl 10 (1992) S115-S118
17. Roman M.J., Devereux R.B., Schwartz J.E., Lockshin M.D., Paget S.A., Davis A., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 46 (2005) 194-199
18. Wittkowski K.M., Lee E., Nussbaum R., Chamian F.N., and Krueger J.G. Combining several ordinal measures in clinical studies. Stat Med 23 (2004) 1579-1592
19. Morales J.F., Song T., Auerbach A.D., and Wittkowski K.M. Phenotyping genetic diseases using an extension of mu-scores for multivariate data. Stat Appl Genet Mol Biol 7 (2008) Article 19
20. Ishiguro H., Ohkubo I., Mizokami M., Titani K., and Sasaki M. The use of monoclonal antibodies to define levels of cystatin C in normal human serum. Hybridoma 8 (1989) 303-313
21. Harmoinen A., Ylinen E., Ala-Houhala M., Janas M., Kaila M., and Kouri T. Reference intervals for cystatin C in pre- and full-term infants and children. Pediatr Nephrol 15 (2000) 105-108
22. Takahashi K., Oharaseki T., and Naoe S. Pathological study of postcoronary arteritis in adolescents and young adults: with reference to the relationship between sequelae of Kawasaki disease and atherosclerosis. Pediatr Cardiol 22 (2001) 138-142
23. Tanaka N., Naoe S., Masuda H., and Ueno T. Pathological study of sequelae of Kawasaki disease (MCLS). With special reference to the heart and coronary arterial lesions. Acta Pathol Jpn 36 (1986) 1513-1527
24. Noto N., Okada T., Yamasuge M., Taniguchi K., Karasawa K., Ayusawa M., et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 107 (2001) 1095-1099
25. Cheung Y.F., Wong S.J., and Ho M.H. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child 92 (2007) 43-47
26. Ikemoto Y., Ogino H., Teraguchi M., and Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 26 (2005) 782-786
27. Cheung Y.F., Ho M.H., Tam S.C., and Yung T.C. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 90 (2004) 1281-1285
28. Cheung Y.F., Yung T.C., Tam S.C., Ho M.H., and Chau A.K. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 43 (2004) 120-124
29. Cheung Y.F., O K, Tam S.C., and Siow Y.L. Induction of MCP1, CCR2, and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease. Pediatr Res 58 (2005) 1306-1310
30. Mitani Y., Sawada H., Hayakawa H., Aoki K., Ohashi H., Matsumura M., et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111 (2005) 38-43
31. Yamakawa R. The vascular function of the long-term coronary artery after Kawasaki disease-evaluation by intracoronary injection of acetylcholine. Kurume Med J 44 (1997) 7-14
32. Iemura M., Ishii M., Sugimura T., Akagi T., and Kato H. Long-term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart 83 (2000) 307-311
33. Sugimura T., Kato H., Inoue O., Takagi J., Fukuda T., and Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr 121 (1992) 684-688
34. McCrindle B.W., Li J.S., Minich L.L., Colan S.D., Atz A.M., Takahashi M., et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116 (2007) 174-179
35. McCrindle B.W., McIntyre S., Kim C., Lin T., and Adeli K. Are patients after Kawasaki disease at increased risk for accelerated atherosclerosis?. J Pediatr 151 (2007) 244-248 8e1
36. Dadlani G.H., Gingell R.L., Orie J.D., Roland J.M., Najdzionek J., Lipsitz S.R., et al. Coronary artery calcifications in the long-term follow-up of Kawasaki disease. Am Heart J 150 (2005) 1016
37. Porteu F., Brockhaus M., Wallach D., Engelmann H., and Nathan C.F. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. J Biol Chem 266 (1991) 18846-18853
38. Gupta M., Noel G.J., Schaefer M., Friedman D., Bussel J., and Johann-Liang R. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol 21 (2001) 193-199
39. Gupta-Malhotra M., Levine D.M., Cooper R.S., and Zabriskie J.B. Decreased levels of cystatin C, an inhibitor of the elastolytic enzyme cysteine protease, in acute and subacute phases of kawasaki disease. Cardiology 99 (2003) 121-125
40. Shi G.P., Sukhova G.K., Grubb A., Ducharme A., Rhode L.H., Lee R.T., et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 104 (1999) 1191-1197